Strategic objectives

The group's research activity is aimed at the design, synthesis and evaluation of small molecules of biological interest or pharmacological activity. For this aim, we collaborate with groups that are experts in validated and emerging targets in different therapeutic areas. The active lines of research focus on the development of new inhibitors of several targets, the search for reagents for cell staining and bioimaging and the development of synthetic methodology applicable to carbo- and heterocycles of biological interest and PET reagents.

Research lines

• Medicinal chemistry strategies in kidney disease.
• Estrategias de Química Médica en la enfermedad renal.
  • Development of new inhibitors on targets involved in kidney disease (calpains, PTP1B and NIK).
  • Vehiculation of PNAs and drugs to the renal environment.
  • Search for alternatives to the use of glucose in peritoneal dialysis solutions.
• Design and study of new chromophores for multiphoton absorption with potential application in cellular staining and bioimaging.
• Development of synthetic methodology for carbo- and heterocycles of biological interest. Organocatalysis. Photocatalysis
• Synthesis, reactivity and applications of BN-arenes.